Experience with long-term use of certolizumab pegol (Cimzia)
Objective: to establish whether long-term combination therapy with a tumor necrosis factor (TNF) α inhibitor and a disease-modifying antirheumatic drug (DMARD) (methotrexate – MTX) may lead to sustained rheumatoid arthritis (RA) remission and its maintenance even after discontinuation of genetically...
Furkejuvvon:
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Russo |
| Almmustuhtton: |
IMA-PRESS LLC
2013-10-01
|
| Ráidu: | Современная ревматология |
| Fáttát: | |
| Liŋkkat: | https://mrj.ima-press.net/mrj/article/view/496 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|